Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$1.57B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$638M |
| 3 |
Medtronic
MDT
|
+$515M |
| 4 |
Alibaba
BABA
|
+$372M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
+$360M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$951M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$786M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$580M |
| 4 |
iShares US Technology ETF
IYW
|
+$570M |
| 5 |
Fastenal
FAST
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.58% |
| 2 | Healthcare | 14.51% |
| 3 | Financials | 13.23% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $4.14B | 2.37% |
132,964,100
+808,024
| +0.6% | +$24.4M |
|
2
JPMorgan Chase
JPM
$939B
| $2.05B | 1.18% |
33,915,557
-3,891,395
| -10% | -$230M |
|
3
Microsoft
MSFT
$2.84T
| $1.96B | 1.13% |
48,299,770
-4,888,388
| -9% | -$213M |
|
4
Alphabet (Google) Class C
GOOG
$3.9T
| $1.93B | 1.11% |
70,318,892
+362,633
| +0.5% | +$9.72M |
|
5
Pfizer
PFE
$140B
| $1.86B | 1.07% |
56,289,292
+3,372,599
| +6% | +$107M |
|
6
Johnson & Johnson
JNJ
$635B
| $1.85B | 1.06% |
18,393,027
+3,424,962
| +23% | +$348M |
|
7
Comcast
CMCSA
$79.1B
| $1.78B | 1.02% |
62,878,520
-2,272,630
| -3% | -$65.3M |
|
|
8
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
| $1.69B | 0.97% |
16,793,226
+14,210,601
| +550% | +$1.57B |
|
9
CVS Health
CVS
$137B
| $1.5B | 0.86% |
14,553,147
+984,415
| +7% | +$99.6M |
|
10
Verizon
VZ
$194B
| $1.48B | 0.85% |
30,438,514
+2,848,595
| +10% | +$137M |
|
11
Cisco
CSCO
$450B
| $1.46B | 0.84% |
53,089,095
+2,229,304
| +4% | +$62.8M |
|
12
Citigroup
C
$222B
| $1.46B | 0.84% |
28,248,646
+2,914,364
| +12% | +$148M |
|
13
Visa
V
$677B
| $1.44B | 0.82% |
21,970,861
-832,943
| -4% | -$55.1M |
|
14
Chevron
CVX
$388B
| $1.41B | 0.81% |
13,453,293
-209,240
| -2% | -$22.3M |
|
15
Wells Fargo
WFC
$261B
| $1.4B | 0.8% |
25,768,397
-380,547
| -1% | -$20.6M |
|
16
Biogen
BIIB
$29.9B
| $1.37B | 0.78% |
3,235,509
+465,986
| +17% | +$184M |
|
17
Merck
MRK
$324B
| $1.32B | 0.76% |
24,034,452
-1,686,407
| -7% | -$95.5M |
|
18
Bristol-Myers Squibb
BMY
$127B
| $1.3B | 0.74% |
20,085,094
+1,033,367
| +5% | +$64.7M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $1.29B | 0.74% |
11,175,692
-828,270
| -7% | -$99M |
|
20
Meta Platforms (Facebook)
META
$1.51T
| $1.27B | 0.73% |
15,413,217
-314,969
| -2% | -$24.7M |
|
|
21
Medtronic
MDT
$107B
| $1.24B | 0.71% |
15,883,406
+6,794,058
| +75% | +$515M |
|
22
Honeywell
HON
$77.1B
| $1.2B | 0.69% |
12,836,368
+38,932
| +0.3% | +$3.56M |
|
23
Vertex Pharmaceuticals
VRTX
$121B
| $1.17B | 0.67% |
9,955,894
+642,075
| +7% | +$76.9M |
|
24
Philip Morris
PM
$301B
| $1.17B | 0.67% |
15,540,488
+3,037,204
| +24% | +$247M |
|
25
Procter & Gamble
PG
$343B
| $1.17B | 0.67% |
14,250,355
-2,353,332
| -14% | -$202M |
|
Similar funds
Ameriprise's Q1 2015 Portfolio in Review
As of Q1 2015, Ameriprise held 4,120 positions worth $174B, up 1.5% from $172B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ameriprise's Q1 2015 filing shows 382 new, 1,994 increased, 1,304 reduced and 183 closed positions. Its largest new stake was Qorvo: 3,629,346 shares worth $289M. The largest sale was PHARMACYCLICS INC, an estimated $951M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q1 2015 buy was Qorvo: 3,629,346 shares worth $289M.
- Ameriprise added most to iShares 0-1 Year Treasury Bond ETF in Q1 2015, an estimated $1.57B increase.
- Ameriprise's biggest Q1 2015 reduction was PHARMACYCLICS INC, cutting an estimated $951M.
- Ameriprise fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $786M.
- Ameriprise's ten largest holdings make up 12% of its $174B portfolio in Q1 2015.
- Ameriprise opened 382 new positions and closed 183 in Q1 2015.
- Ameriprise's portfolio value rose 1.5% quarter-over-quarter to $174B.
Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.